Huining He - Search Results

Year	Number of Results
2010	1
2012	1
2013	6
2014	7
2015	6
2016	10
2017	8
2018	4
2019	2
2020	3
2021	1
2022	3
2023	2
2024	2

1

mRNA vaccines for COVID-19 and diverse diseases.

Hussain A, Yang H, Zhang M, Liu Q, Alotaibi G, Irfan M, He H, Chang J, Liang XJ, Weng Y, Huang Y. Hussain A, et al. Among authors: he h. J Control Release. 2022 May;345:314-333. doi: 10.1016/j.jconrel.2022.03.032. Epub 2022 Mar 21. J Control Release. 2022. PMID: 35331783 Free PMC article. Review.

2

Heparin-Regulated Prodrug-Type Macromolecular Theranostic Systems for Cancer Therapy.

Wang H, Moon C, Shin MC, Wang Y, He H, Yang VC, Huang Y. Wang H, et al. Among authors: he h. Nanotheranostics. 2017 Mar 3;1(1):114-130. doi: 10.7150/ntno.18292. eCollection 2017. Nanotheranostics. 2017. PMID: 29071181 Free PMC article. Review.

3

CPP-Assisted Intracellular Drug Delivery, What Is Next?

Ye J, Liu E, Yu Z, Pei X, Chen S, Zhang P, Shin MC, Gong J, He H, Yang VC. Ye J, et al. Among authors: he h. Int J Mol Sci. 2016 Nov 14;17(11):1892. doi: 10.3390/ijms17111892. Int J Mol Sci. 2016. PMID: 27854260 Free PMC article. Review.

4

Enzyme-triggered, cell penetrating peptide-mediated delivery of anti-tumor agents.

He H, Sun L, Ye J, Liu E, Chen S, Liang Q, Shin MC, Yang VC. He H, et al. J Control Release. 2016 Oct 28;240:67-76. doi: 10.1016/j.jconrel.2015.10.040. Epub 2015 Oct 26. J Control Release. 2016. PMID: 26514292 Review.

5

CPP mediated insulin delivery: current status and promising future.

Liu E, Sheng J, Ye J, Wang Y, Gong J, Yang VC, Wang J, He H. Liu E, et al. Among authors: he h. Curr Pharm Biotechnol. 2014;15(3):240-55. doi: 10.2174/1389201015666140813125840. Curr Pharm Biotechnol. 2014. PMID: 25312540 Review.

6

Cell-penetrating peptide enhanced insulin buccal absorption.

Xu Y, Zhang X, Wang N, Pei X, Guo Y, Wang J, Barth S, Yu F, Lee SJ, He H, Yang VC. Xu Y, et al. Among authors: he h. Int J Pharm. 2020 Jun 30;584:119469. doi: 10.1016/j.ijpharm.2020.119469. Epub 2020 May 26. Int J Pharm. 2020. PMID: 32470482

7

Biosafety materials: Ushering in a new era of infectious disease diagnosis and treatment with the CRISPR/Cas system.

Zhang Y, Li Z, Milon Essola J, Ge K, Dai X, He H, Xiao H, Weng Y, Huang Y. Zhang Y, et al. Among authors: he h. Biosaf Health. 2022 Apr;4(2):70-78. doi: 10.1016/j.bsheal.2022.03.010. Epub 2022 Mar 14. Biosaf Health. 2022. PMID: 35310559 Free PMC article. Review.

8

Cell-penetrating peptides: achievements and challenges in application for cancer treatment.

Shin MC, Zhang J, Min KA, Lee K, Byun Y, David AE, He H, Yang VC. Shin MC, et al. Among authors: he h. J Biomed Mater Res A. 2014 Feb;102(2):575-87. doi: 10.1002/jbm.a.34859. Epub 2013 Jul 30. J Biomed Mater Res A. 2014. PMID: 23852939 Free PMC article. Review.

9

Lipid core-shell nanoparticles co-deliver FOLFOX regimen and siPD-L1 for synergistic targeted cancer treatment.

Cao W, Zhang X, Li R, Li Z, Lu A, Yu F, Sun L, Wang J, Wang Z, He H. Cao W, et al. Among authors: he h. J Control Release. 2024 Apr;368:52-65. doi: 10.1016/j.jconrel.2024.02.025. Epub 2024 Feb 21. J Control Release. 2024. PMID: 38368946

10

A novel strategy to achieve effective drug delivery: exploit cells as carrier combined with nanoparticles.

Pang L, Zhang C, Qin J, Han L, Li R, Hong C, He H, Wang J. Pang L, et al. Among authors: he h. Drug Deliv. 2017 Nov;24(1):83-91. doi: 10.1080/10717544.2016.1230903. Drug Deliv. 2017. PMID: 28155538 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

50 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

50 results

Results by year